Skip to main content
Equibles

Bradley Campbell

Board Member

Travere Therapeutics, Inc. (TVTX)

CEO

Travere Therapeutics, Inc. (TVTX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Bradley Campbell

Bradley Campbell is recorded as Board Member and CEO at Travere Therapeutics, Inc. (TVTX). Travere Therapeutics, Inc. reported in an 8-K filed September 21, 2026 that Bradley Campbell was appointed Board of Directors, effective December 1, 2026. Travere Therapeutics, Inc. reported in an 8-K filed September 21, 2026 that Bradley Campbell was appointed President and Chief Executive Officer, effective December 1, 2026.

“1.4 Board of Directors. The Company shall appoint Executive to serve on the Board of Directors of the Company (the “Board”) as of the Start Date and, for so long as this Agreement remains in effect, shall renominate Executive to continue on the Board when any applicable Board term expires.”
Travere Therapeutics, Inc. Form 8-K, filed September 21, 2026 · Read the filing
“1.1 Start Date of Employment. Executive’s employment with the Company shall begin on December 1, 2026 or such date as otherwise agreed to by Executive and the Company (such actual date Executive’s employment begins (the “Start Date”)).”
Travere Therapeutics, Inc. Form 8-K, filed September 21, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Travere Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.